Price Performance and Market Context
On 23 Dec 2025, National Peroxide's share price recorded a decline of 1.78%, underperforming the Sensex which showed a marginal fall of 0.02%. Over the past week, the stock has moved down by 1.42%, contrasting with the Sensex's gain of 1.03%. The one-month trend reveals a sharper movement, with the stock falling 14.69% while the Sensex posted a modest 0.37% rise. The three-month period further emphasises the stock's relative weakness, with a 22.57% decline against the Sensex's 4.20% increase.
Yearly figures highlight a more pronounced disparity: National Peroxide's stock has declined by 43.41% over the last 12 months, whereas the Sensex has advanced by 8.93%. Year-to-date performance also shows a similar pattern, with the stock down 41.25% compared to the Sensex's 9.49% gain.
Longer-term data indicates stagnation in the stock's value, with no recorded gains over three, five, and ten-year periods, while the Sensex has appreciated by 42.95%, 84.20%, and 230.95% respectively over the same durations. This contrast underscores the stock's persistent underperformance relative to broader market benchmarks.
Technical Indicators and Trading Levels
National Peroxide is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a sustained bearish trend in the stock's price action. The proximity to its 52-week low further highlights the stock's vulnerability in the current market environment.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Financial Performance and Profitability Metrics
National Peroxide's financial results over recent periods reveal significant challenges. The latest six-month profit after tax (PAT) stands at ₹1.28 crore, reflecting a contraction of 77.78% compared to prior periods. Non-operating income for the quarter accounts for 263.49% of profit before tax (PBT), indicating a substantial portion of earnings derived from sources outside core operations.
Operating profits have shown a compound annual growth rate (CAGR) of -135.58% over the last five years, signalling a persistent decline in earnings generated from the company's primary business activities. This trend is further reflected in the company's return on equity (ROE), which averages 1.90%, suggesting limited profitability relative to shareholders' funds.
The company's capacity to service its debt is constrained, with an average EBIT to interest ratio of 0.14, indicating that earnings before interest and tax cover only a small fraction of interest obligations. This metric points to a heightened risk profile in terms of financial leverage and debt servicing ability.
Valuation and Risk Considerations
National Peroxide's stock is trading at levels considered risky when compared to its historical valuation averages. Over the past year, the stock's return of -43.41% coincides with a 113% decline in profits, underscoring the disconnect between market value and earnings performance. The stock has also underperformed the BSE500 index over the last three months, one year, and three years, reinforcing its relative weakness within the broader market context.
Majority ownership remains with promoters, which may influence strategic decisions and capital allocation going forward.
Why settle for National Peroxide ? SwitchER evaluates this Commodity Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Recent Trends
National Peroxide's share price has demonstrated a consistent downward trajectory across multiple time horizons. The stock's performance contrasts sharply with broader market indices, which have shown positive returns over the same periods. The company's financial indicators reveal subdued profitability, limited earnings growth, and challenges in covering interest expenses.
Trading below all key moving averages and near its 52-week low, the stock's technical and fundamental profiles suggest a period of sustained pressure. The prominence of non-operating income in recent earnings further highlights the limited contribution from core business activities.
While the stock remains under the control of promoters, the prevailing financial and market data depict a company facing significant headwinds in both earnings generation and market valuation.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
